483
Hospira, Inc., A Pfizer CompanyFDA 483 - Hospira, Inc., A Pfizer Company - September 12, 2002
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Abbott Laboratories in McPherson, KS, revealed significant deficiencies in procedures designed to prevent microbiological contamination of sterile drug products. The firm lacked an adequate environmental monitoring program, failed to monitor all personnel entering aseptic processing areas daily, and had not properly evaluated airflow patterns with smoke studies for component transfer and sealing activities.
Open in Dashboard
ID · 2091e659-230d-47bd-892c-11d347ec23db